PEDIATRICS Vol. 83 No. 6 June 1989, pp. 915-920
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van de Bor, M.
Right arrow Articles by Ruys, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van de Bor, M.
Right arrow Articles by Ruys, J. H.

Hyperbilirubinemia in Preterm Infants and Neurodevelopmental Outcome at 2 Years of Age: Results of a National Collaborative Survey

Margot van de Bor MD, PhD1, Thea M. van Zeben-van der Aa MD1, S. Pauline Verloove-Vanhorick MD, PhD1, Ronald Brand PhD1, and Jan H. Ruys MD, PhD1

1 The Collaborative Project on Preterm and Small for Gestational Age Infants in the Netherlands, 1983, Departments of Pediatrics and Medical Statistics, University Hospital, Leiden, the Netherlands

As part of a prospective national survey of preterm and small for gestational age infants in the Netherlands, the relationship between maximal serum total bilirubin concentration in the neonatal period and neurodevelopmental outcome at the corrected age of 2 years was studied. Initially, 1,338 infants with a gestational age of less than 32 completed weeks and/or a birth weight of less than 1,500 g were enrolled in the study; 146 were subsequently excluded because of congenital malformations and 361 died during the study period. At the corrected age of 2 years, 831 children were available for follow-up. Children with minor and major handicaps had significantly greater maximal serum total bilirubin concentrations than children with a normal neurodevelopmental outcome (P = .02). A consistent increase in prevalence of handicaps was found for each 50-µmol/L (2.9 mg/dL) increase of maximal serum total bilirubin concentration. The handicaps consisted mainly of cerebral palsy. Logistic regression analysis involving seven suspected confounding factors (gestational age, birth weight, seizures, intracranial hemorrhage, respiratory distress syndrome, ventriculomegaly, and bronchopulmonary dysplasia) revealed that the odds ratio was 1.3. This indicates that, on a multiplicative scale, the risk of a handicap increased by 30% for each 50-µmol/L (2.9 mg/dL) increase of maximal serum total bilirubin concentration (P = .02). Further analysis treated bilirubin as a categorized exposure. A striking systematic increase was found, suggesting a causal relationship between maximal serum total bilirubin concentration and neurodevelopmental outcome.

Key Words: hyperbilirubinemia • jaundice • neurodevelopment • preterm infant

Submitted on August 15, 1988
Accepted on November 1, 1988




This article has been cited by other articles:


Home page
 The Journal of the Royal Society for the Promotion of HealthHome page
D. B Shortland, M. Hussey, and A. Dey Chowdhury
Understanding neonatal jaundice: UK practice and international profile
The Journal of the Royal Society for the Promotion of Health, July 1, 2008; 128(4): 202 - 206.
[Abstract] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
J F Watchko and M J Maisels
Jaundice in low birthweight infants: pathobiology and outcome
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2003; 88(6): F455 - 458.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
M J Maisels and J F Watchko
Treatment of jaundice in low birthweight infants
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2003; 88(6): F459 - 463.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
W. Oh, J. E. Tyson, A. A. Fanaroff, B. R. Vohr, R. Perritt, B. J. Stoll, R. A. Ehrenkranz, W. A. Carlo, S. Shankaran, K. Poole, et al.
Association Between Peak Serum Bilirubin and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants
Pediatrics, October 1, 2003; 112(4): 773 - 779.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. A. Dennery, D. S. Seidman, and D. K. Stevenson
Neonatal Hyperbilirubinemia
N. Engl. J. Med., February 22, 2001; 344(8): 581 - 590.
[Full Text] [PDF]